The U.S. Attorney's Office in the Southern District of New York charged a Long Island woman with smuggling, receiving, dispensing and delivering misbranded, injected weight loss drugs, including Ozempic, Mesofrance, and Acxion.

As alleged, the defendant, who is not licensed to prescribe or administer prescription medication, promoted and sold medicines she had acquired from Latin America to TikTok followers.

One customer developed lesions from a serious bacterial infection after injecting Mesofrance the defendant allegedly sold her.

A federal grand jury in Florida filed an indictment charging the owners of Safe Chain Solutions, Adam Brosius, Patrick Boyd and Charles Boyd, for selling $90 million of heavily discounted and diverted prescription drugs, primarily HIV medication, from five black-market suppliers. Maryland-based Safe Chain Solutions signed a $2.7 million lawsuit in February over accusations that they distributed millions of dollars worth of counterfeit and diverted HIV medicines. Allegedly, Safe Chain was part of a huge network of companies that put more than 85,000 bottles of fake HIV medicines in the U.S. drug supply chain.

Homeland Security Investigations agents in Houston, Texas arrested an Indian national for alleged trafficking and distribution of counterfeit cancer treatments, including Keytruda.

In March, Delhi police busted a ring that sold vials labeled as cancer treatments filled with an anti-fungal.

Keytruda is one of the medicines that ring counterfeited. Watch to learn more.

Read these and other counterfeit drug stories you may have missed.

USA v Isis Navarro Reyes

In or about January 2024, Isis Navarro Reyes allegedly received and caused the receipt in interstate commerce of a misbranded drug (an article labeled as "Ozempic") and did deliver and proffer delivery of such drug for pay and otherwise. Read the complaint.

USA v Paul Z. Lamberty

Lamberty and coconspirators allegedly purchased drugs (etizolam) from suppliers in China, imported the drugs in the US, mislabeled the drugs and used multiple delivery addresses to avoid detection by United States Customs and Border Protection, and sold drugs with false labeling stating that products were sold "For Research Purposes Only" and "Not for Human Consumption." Read the document.